Funded Tech Companies

Audentes Therapeutics

Audentes Therapeutics, operating out of San Francisco, has financial backing through OrbiMed, Deerfield Capital and Cowen Capital Partners.

Company Overview

Contact Information

Company Background Information

Overview

Audentes Therapeutics (NASDAQ: BOLD) is a biotechnology company committed to the development and commercialization of innovative new gene therapy treatments for people with serious rare diseases. We are a focused, experienced and passionate team driven by the goal of improving the lives of patients.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

7/20/2016

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Matthew Patterson

        

Chief Financial Officer

Thomas Soloway

        

Chief Operating Officer

Natalie Holles

        

Vice President

Fulvio Mavilio

        

VP - Regulatory Affairs

Mary Newman

        

Company Investors

• OrbiMed (Jonathan Silverstein)
• Deerfield Capital (Jonathan Leff)
• Cowen Capital Partners
• Venrock
• Rock Springs Capital
• Foresite Capital
• 5AM Ventures (Kush Parmar)
• Versant Ventures (Thomas Woiwode)
• Sofinnova Ventures
• RA Capital
• Cormorant Asset Management
• T. Rowe Price
• Redmile Group

Browse more funded tech companies:

Auddy | Audette

Share this article

About Our Venture Capital Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary